Growth Equity

Czechoslovak Group's record-breaking €3.8B IPO on Euronext Amsterdam sees shares soar, signaling a major geopolitical shift in investor sentiment.

With a strategic hire from PointClickCare, Lifespark is set to scale its high-occupancy, integrated health model and challenge the senior living industry.

India's 'Vaccine Capital' unveils a bold new policy at Davos, shifting from manufacturing to high-value innovation to join the world's top life sciences hubs.

An Israeli startup's laser-based processor is making waves in high-performance computing, offering a practical, room-temperature alternative to quantum.

With new CEO Christopher J. Pino, BioTown Biogas aims to scale its pioneering waste-to-RNG operations, backed by private equity and a booming green market.

As restaurants face a historic labor crisis, Aniai's automated Alpha Grill lands in U.S. kitchens, promising speed, consistency, and a new era of dining.

GSK's subsidiary Tesaro inks a deal worth up to $285M with Alteogen to create an under-the-skin version of its cancer drug Jemperli.

The Canadian fertility network appoints former CFO Heather Stark as its first female CEO, signaling a strategic shift toward operational excellence and growth.

A historic $5M donation from an alumna and her husband will fund scholarships at Neumann University, tackling the nursing shortage and boosting social mobility.

Following key acquisitions, Ntracts promotes six executives, signaling a major push to unify its platform and tackle healthcare's growing complexity.

A $24M Dept. of War grant will accelerate production of Seasats' proven autonomous boats, fueling the US Navy's strategic shift to a hybrid fleet.

With a fresh half-billion in capital, Renewa is buying the ground beneath renewable projects, unlocking a critical bottleneck in the clean energy transition.

Four startups won the UAE FoodTech Challenge, sharing $2M to scale their solutions for food production and waste reduction from the UAE to the Global South.

Lead Capital Partners' strategic investment in PedsOne signals a growing focus on specialized services that help independent doctors navigate financial pressures.

Top 25 firm Aprio unveils its 'Account for Anything™' rebrand, signaling a strategic pivot to integrated advisory in an increasingly complex market.

With a veteran from Adobe and Dropbox at the helm, the restaurant tech unicorn is poised to scale its AI-driven platform and solidify market leadership.

With a promising brain injury drug and no approved rivals, Oragenics heads to a tax-haven investor summit to secure funding for its next critical phase.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

As AI firm CluePoints expands globally, new CPO Sinead Godkin is tasked with scaling its human capital to match the pace of its technological innovation.

With a former mayor and Airbnb policy chief now in its C-suite, EverDriven signals a push to rewrite the rules for getting vulnerable students to school.